Medicover (MCOV B) Stock Overview
Provides healthcare and diagnostic services in Poland, Sweden, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
MCOV B Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Medicover AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 236.00 |
| 52 Week High | SEK 295.00 |
| 52 Week Low | SEK 170.40 |
| Beta | 1.76 |
| 1 Month Change | -9.23% |
| 3 Month Change | -11.94% |
| 1 Year Change | 34.55% |
| 3 Year Change | 56.40% |
| 5 Year Change | 83.51% |
| Change since IPO | 260.31% |
Recent News & Updates
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger
Sep 24
Medicover AB (publ) (STO:MCOV B) Not Lagging Industry On Growth Or Pricing
Sep 01Recent updates
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger
Sep 24Medicover AB (publ) (STO:MCOV B) Not Lagging Industry On Growth Or Pricing
Sep 01Medicover AB (publ) Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next
Jul 27Medicover (STO:MCOV B) Seems To Use Debt Quite Sensibly
Jul 22Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point
May 09Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 41% Above Its Share Price
Apr 28Investors Interested In Medicover AB (publ)'s (STO:MCOV B) Revenues
Apr 14Medicover (STO:MCOV B) Might Be Having Difficulty Using Its Capital Effectively
Mar 21
New Investments In India's And Romania's Healthcare Services Will Expand Future Global Reach
Strong cash generation supports debt reduction and further investments, boosting future earnings growth positively.Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear
Dec 12The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business
Nov 07Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return
Oct 24Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects
Apr 22Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings
Apr 04Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet
Mar 05Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price
Feb 11Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture
Dec 20Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?
Dec 02Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business
Sep 12Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet
Aug 21Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?
Jun 12Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends
May 27Is Medicover (STO:MCOV B) Using Too Much Debt?
May 12Shareholder Returns
| MCOV B | SE Healthcare | SE Market | |
|---|---|---|---|
| 7D | -9.4% | -6.9% | -2.3% |
| 1Y | 34.5% | 33.7% | 0.5% |
Return vs Industry: MCOV B matched the Swedish Healthcare industry which returned 34.7% over the past year.
Return vs Market: MCOV B exceeded the Swedish Market which returned 2.8% over the past year.
Price Volatility
| MCOV B volatility | |
|---|---|
| MCOV B Average Weekly Movement | 2.6% |
| Healthcare Industry Average Movement | 4.4% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.6% |
| 10% least volatile stocks in SE Market | 2.9% |
Stable Share Price: MCOV B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: MCOV B's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 47,000 | John Stubbington | www.medicover.com |
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company’s Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.
Medicover AB (publ) Fundamentals Summary
| MCOV B fundamental statistics | |
|---|---|
| Market cap | SEK 35.63b |
| Earnings (TTM) | SEK 744.02m |
| Revenue (TTM) | SEK 25.67b |
Is MCOV B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCOV B income statement (TTM) | |
|---|---|
| Revenue | €2.32b |
| Cost of Revenue | €1.79b |
| Gross Profit | €534.30m |
| Other Expenses | €467.00m |
| Earnings | €67.30m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 10, 2026
| Earnings per share (EPS) | 0.45 |
| Gross Margin | 23.01% |
| Net Profit Margin | 2.90% |
| Debt/Equity Ratio | 170.2% |
How did MCOV B perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/06 08:56 |
| End of Day Share Price | 2025/11/06 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medicover AB (publ) is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| null null | ABG Sundal Collier Sponsored |
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |